Vimarsana.com

option rights: Live & Latest News Updates : Vimarsana.com

Brembo S p A : OPTION RIGHT OFFER NOTICE -Today at 04:58 am

does not exceed a total amount of Euro 200,000,000 ; in this regard, the Company's controlling shareholder Nuova Fourb S.r.l., with the aim of reducing the potential...

Netherlands
Stezzano
Lombardia
Italy
Brembo
Italy-general-
Italian
Borsa-italiana
Nuova-fourb
Monte-titoli
Bergamo-companies-register-the-registration
Office-relocation

Tessellis S p A : Outcome of today's BoD about capital increase

Tiscali Capital Increase: OPNET S.p.A.formalizes a further commitment to subscribe to the capital increase, covering its full share, amounting to... | June 20, 2023

Australia
Italy
United-states
Milan
Lombardia
Sa-illetta
Sardegna
Canada
Cagliari
Italian
Tiscali-italia
Patrizia-tammaro

BBS-Bioactive Bone Substitutes Oyj: BBS arranges a rights offering of approximately maximum EUR 2.9 million

BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider information, 5 June 2023 at 09.00 a.m. EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE USA

Finland
South-africa
Canada
Netherlands
United-states
New-zealand
Sweden
Hong-kong
Japan
Singapore
Australia
Finnish


acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Macau
China
Taiwan
Hong-kong
Zhejiang
Tokyo
Japan
Hangzhou
Bliss-biopharmaceuticals-hangzhou-co-ltd
Eisai-enters-into-joint-development-agreement
Bliss-biopharmaceutical-hangzhou-co-ltd

Eisai Enters Into Joint Development Agreement with Blissbio for Antibody Drug Conjugate BB-1701 with Option Rights for Strategic Collaboration

Eisai Enters Into Joint Development Agreement with Blissbio for Antibody Drug Conjugate BB-1701 with Option Rights for Strategic Collaboration
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Eisai-enters-into-joint-development-agreement
Antibody-drug-conjugate
Option-rights

vimarsana © 2020. All Rights Reserved.